Literature DB >> 26145788

Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer.

Trisha A Rettig1, Julie N Harbin2, Adelaide Harrington1, Leonie Dohmen1, Sherry D Fleming3.   

Abstract

The humoral innate immune system is composed of three major branches, complement, coagulation, and natural antibodies. To persist in the host, pathogens, such as bacteria, viruses, and cancers must evade parts of the innate humoral immune system. Disruptions in the humoral innate immune system also play a role in the development of autoimmune diseases. This review will examine how Gram positive bacteria, viruses, cancer, and the autoimmune conditions systemic lupus erythematosus and anti-phospholipid syndrome, interact with these immune system components. Through examining evasion techniques it becomes clear that an interplay between these three systems exists. By exploring the interplay and the evasion/disruption of the humoral innate immune system, we can develop a better understanding of pathogenic infections, cancer, and autoimmune disease development.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B1 B cells; Cancer; Coagulation; Complement; Natural antibodies; Pathogens; SLE

Mesh:

Substances:

Year:  2015        PMID: 26145788      PMCID: PMC4581967          DOI: 10.1016/j.clim.2015.06.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  185 in total

1.  Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors.

Authors:  Joseph R Tumang; Rubén Francés; Seung Geun Yeo; Thomas L Rothstein
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

Review 2.  Novel biological networks modulated by complement.

Authors:  Dimitrios Mastellos; Christos Andronis; Andreas Persidis; John D Lambris
Journal:  Clin Immunol       Date:  2005-06       Impact factor: 3.969

3.  Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.

Authors:  Charles C Chu; Rosa Catera; Lu Zhang; Sebastien Didier; Briana M Agagnina; Rajendra N Damle; Matthew S Kaufman; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

4.  Thrombin drives tumorigenesis in colitis-associated colon cancer.

Authors:  Brian Turpin; Whitney Miller; Leah Rosenfeldt; Keith Kombrinck; Matthew J Flick; Kris A Steinbrecher; Eleana Harmel-Laws; Eric S Mullins; Maureen Shaw; David P Witte; Alexey Revenko; Brett Monia; Joseph S Palumbo
Journal:  Cancer Res       Date:  2014-04-07       Impact factor: 12.701

5.  Coagulation factor VII is regulated by androgen receptor in breast cancer.

Authors:  Ali Naderi
Journal:  Exp Cell Res       Date:  2014-10-14       Impact factor: 3.905

Review 6.  Targeting kallikrein-related peptidases in prostate cancer.

Authors:  Konstantinos Mavridis; Margaritis Avgeris; Andreas Scorilas
Journal:  Expert Opin Ther Targets       Date:  2014-02-27       Impact factor: 6.902

Review 7.  Regulatory T cells and immune tolerance to tumors.

Authors:  Xuefang Cao
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

8.  C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.

Authors:  Christopher Sjöwall; Anders I Olin; Thomas Skogh; Jonas Wetterö; Matthias Mörgelin; Ola Nived; Gunnar Sturfelt; Anders A Bengtsson
Journal:  Autoimmunity       Date:  2013-02-25       Impact factor: 2.815

9.  Multiple ligands of von Willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma.

Authors:  Lena Thomer; Olaf Schneewind; Dominique Missiakas
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

10.  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  4 in total

1.  Synthetic Immunotherapeutics against Gram-negative Pathogens.

Authors:  Mary Sabulski Feigman; Seonghoon Kim; Sean E Pidgeon; Yuming Yu; George Mogambi Ongwae; Dhilon S Patel; Steven Regen; Wonpil Im; Marcos M Pires
Journal:  Cell Chem Biol       Date:  2018-07-05       Impact factor: 8.116

2.  Therapeutic Potential of Inducible Endogenous Cytoprotective Heme Oxygenase-1 in Mitigating SARS-CoV-2 Infection and Associated Inflammation.

Authors:  Subhash Dhawan
Journal:  Antioxidants (Basel)       Date:  2022-03-30

3.  Distinct herpesvirus resistances and immune responses of three gynogenetic clones of gibel carp revealed by comprehensive transcriptomes.

Authors:  Fan-Xiang Gao; Yang Wang; Qi-Ya Zhang; Cheng-Yan Mou; Zhi Li; Yuan-Sheng Deng; Li Zhou; Jian-Fang Gui
Journal:  BMC Genomics       Date:  2017-07-24       Impact factor: 3.969

Review 4.  Evolution and Function of Thioester-Containing Proteins and the Complement System in the Innate Immune Response.

Authors:  Upasana Shokal; Ioannis Eleftherianos
Journal:  Front Immunol       Date:  2017-06-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.